These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 11438874)

  • 1. [Lipids and age-related macular degeneration].
    García-Layana A; Sainz Gómez C; Fernández Robredo P; Rodríguez Fernández JA
    Arch Soc Esp Oftalmol; 2001 Jul; 76(7):395-6. PubMed ID: 11438874
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholesterol and age-related macular degeneration: is there a link?
    van Leeuwen R; Klaver CC; Vingerling JR; Hofman A; van Duijn CM; Stricker BH; de Jong PT
    Am J Ophthalmol; 2004 Apr; 137(4):750-2. PubMed ID: 15059717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in lipid metabolism in women with age-related macular degeneration.
    Nowak M; Swietochowska E; Marek B; Szapska B; Wielkoszynski T; Kos-Kudla B; Karpe J; Kajdaniuk D; Sieminska L; Glogowska-Szelag J; Nowak K
    Clin Exp Med; 2005 Mar; 4(4):183-7. PubMed ID: 15750765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Von Willebrand factor in plasma of patients with age related macular degeneration].
    Malukiewicz-Wiśniewska G; Rość D; Kałuzny B; Kałuzny JJ
    Klin Oczna; 2005; 107(1-3):70-2. PubMed ID: 16052806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations in some pathogenetic factors and values of hemorheological parameters in age-related macular degeneration.
    Michalska-Malecka K; Slowinska L; Dorecka M; Romaniuk W
    Clin Hemorheol Microcirc; 2008; 38(3):209-16. PubMed ID: 18239263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macular pigment and age-related macular degeneration: longitudinal data and better techniques of measurement are needed.
    Beatty S; van Kuijk FJ; Chakravarthy U
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):843-5. PubMed ID: 18326700
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.
    Tan JS; Mitchell P; Smith W; Wang JJ
    Ophthalmology; 2007 Jun; 114(6):1143-50. PubMed ID: 17275090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of apolipoprotein E polymorphism with age-related macular degeneration and Alzheimer's disease in south-western Hungary.
    Kovács KA; Pámer Z; Kovács A; Fekete S; Miseta A; Kovács B; Kovács GL
    Ideggyogy Sz; 2007 Mar; 60(3-4):169-72. PubMed ID: 17451062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Age related macular degeneration and C-reactive protein].
    Stefan C; Dumitrica DM; Tebeanu E; Sapundgieva A; Dragomir L; Cristea I
    Oftalmologia; 2008; 52(3):73-6. PubMed ID: 19149122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenesis of age-related macular degeneration].
    Kaarniranta K; Seitsonen S; Paimela T; Meri S; Immonen I
    Duodecim; 2009; 125(2):145-53. PubMed ID: 19341030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration?
    Guymer RH; Chiu AW; Lim L; Baird PN
    Surv Ophthalmol; 2005; 50(2):194-206. PubMed ID: 15749309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum leptin concentrations are decreased and correlated with disease severity in age-related macular degeneration: a preliminary study.
    Evereklioglu C; Doganay S; Er H; Cekmen M; Ozerol E; Otlu B
    Eye (Lond); 2003 Apr; 17(3):350-5. PubMed ID: 12724698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of plasma homocysteine and risk of age-related macular degeneration.
    Seddon JM; Gensler G; Klein ML; Milton RC
    Am J Ophthalmol; 2006 Jan; 141(1):201-3. PubMed ID: 16387004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse models may provide new insight into the relation between cholesterol and age related macular degeneration.
    Duncan JL
    Br J Ophthalmol; 2005 Dec; 89(12):1549-51. PubMed ID: 16299127
    [No Abstract]   [Full Text] [Related]  

  • 15. The burden of age-related macular degeneration: a value-based analysis.
    Brown MM; Brown GC; Sharma S; Stein JD; Roth Z; Campanella J; Beauchamp GR
    Curr Opin Ophthalmol; 2006 Jun; 17(3):257-66. PubMed ID: 16794438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Age-related macular degeneration; therapeutic options].
    La Heij EC; Liem AT; Hendrikse F
    Ned Tijdschr Geneeskd; 2001 Jul; 145(29):1390-7. PubMed ID: 11494688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical studies to implement Rheopheresis for age-related macular degeneration guided by evidence-based-medicine.
    Klingel R; Fassbender C; Fassbender T; Göhlen B
    Transfus Apher Sci; 2003 Aug; 29(1):71-84. PubMed ID: 12877897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.
    Tomany SC; Wang JJ; Van Leeuwen R; Klein R; Mitchell P; Vingerling JR; Klein BE; Smith W; De Jong PT
    Ophthalmology; 2004 Jul; 111(7):1280-7. PubMed ID: 15234127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum lipid profile in non-exudative AMD patients treated with locally administrated beta-blockers].
    Gebka A; Iwaszkiewicz-Bilikiewicz B; Raczyńska K; Homziuk M; Ciechanowski C
    Klin Oczna; 2004; 106(3 Suppl):407-8. PubMed ID: 15636216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study.
    Klein R; Klein BE; Tomany SC; Cruickshanks KJ
    Ophthalmology; 2003 Jun; 110(6):1273-80. PubMed ID: 12799274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.